Jiaqian Pan
Yangtze River Delta Integration Demonstration Zone
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Real-world pharmacological treatment of patients with hyperemesis gravidarum in 9 cities of China from 2019 to 2024: a cross-sectional analysis.
Journal: Frontiers in pharmacology
Published: March 12, 2026
Real world drug treatment models for pregnancy complicated with urinary tract infection in China from 2018 to 2022: a cross-section analysis.
Journal: Frontiers in pharmacology
Published: December 04, 2023
Gene polymorphism and prediction of toxicity to platinum-based chemotherapy in patients with gynecologic cancer.
Journal: Clinical and translational science
Published: June 29, 2023
nH115a, a novel inhibitor of the La protein: Effect on expression of multiple RNAs in hepatitis B virus-infected hepatoma cells and embryotoxicity profile.
Journal: Acta virologica
Published: April 05, 2022
La protein contributes to cells proliferation and migration and serves as a potential therapeutic target for hepatocellular carcinoma.
Journal: Asia-Pacific journal of clinical oncology
Published: May 14, 2019
Study on the structure optimization and anti-hepatitis B virus activity of novel human La protein inhibitor HBSC11.
Journal: Journal of medical virology
Published: January 12, 2019
Patient compliance with antimicrobial drugs: A Chinese survey.
Journal: American journal of infection control
Published: September 16, 2017
Alteration of microRNA profiles by a novel inhibitor of human La protein in HBV-transformed human hepatoma cells.
Journal: Journal of medical virology
Published: June 03, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026